PharmaGeddon Part XVI :MERGERS

Novartis and GlaxoSmithKline, two of the world's top drugmakers :

have struck a multi-billion-dollar deal to join forces and reshape their businesses...

The deal involves swapping assets and combining their consumer health units.

Novartis will acquire GSK's cancer drugs business for $16bn:

and sell its vaccines division, excluding the flu unit ,

to GSK for $7.1bn.....

Novartis said the deals would help to strengthen its financial position

                     

In a separate deal, Novartis has agreed to sell its animal health division to Lilly:

for nearly $5.4bn.....

Novartis AG (NVS)
-NYSE
86.54 Up 1.08(1.26%) 3:37PM EDT - Nasdaq Real Time Price

               

US drugs giant Pfizer has confirmed it has contacted AstraZeneca :

over a possible multi-billion pound takeover.

AstraZeneca manufactures drugs in 16 countries focusing on treatments for diabetes, cancer

asthma as well as antibiotics.

[quote author=Goog Lee link=topic=89188.msg560469#msg560469 date=1398195503]
Novartis AG (NVS)
-NYSE
86.54 Up 1.08(1.26%) 3:37PM EDT - Nasdaq Real Time Price
[/quote]

See how these guys are MERGING  >